Francis Duhay - Sep 15, 2025 Form 4 Insider Report for enVVeno Medical Corp (NVNO)

Role
Director
Signature
/s/ Francis Duhay
Stock symbol
NVNO
Transactions as of
Sep 15, 2025
Transactions value $
-$4,067
Form type
4
Date filed
9/17/2025, 09:00 AM
Previous filing
Jan 3, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Duhay Francis Director C/O ENVVENO MEDICAL CORPORATION,, 70 DOPPLER, IRVINE /s/ Francis Duhay 2025-09-17 0001760582

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVNO Common Stock Sale -$4.07K -4.9K -4.79% $0.83 97.4K Sep 15, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025.
F2 This transaction was executed in multiple trades during the day at prices ranging from $0.8205 to $0.84, inclusive. The weighted-average price is reported above. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were completed.